The present invention is directed to pharmaceutical and therapeutic compositions whichcomprise RNA complexes comprising an antisense strand and a discontinued passengerstrand capable of regulating gene expression. The use of a discontinued passengerstrand reduces off target effects of the RNA complexes and also has other advantages.